Scarica l'app Stockscreener
42.61
3.62%
1.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$41.12
Aprire:
$41.91
Volume 24 ore:
1.39M
Relative Volume:
1.25
Capitalizzazione di mercato:
$1.23B
Reddito:
$915.25M
Utile/perdita netta:
$131.14M
Rapporto P/E:
9.5282
EPS:
4.472
Flusso di cassa netto:
$96.71M
1 W Prestazione:
+0.40%
1M Prestazione:
+1.86%
6M Prestazione:
-55.27%
1 anno Prestazione:
-67.15%
Intervallo 1D:
$39.73
$42.73
Intervallo di 1 settimana:
$39.73
$44.53
Portata 52W:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
42.61 | 1.23B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical Systems Inc (INSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inspire Medical Systems Inc (INSP) Institutional Confidence - TradingKey
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems Inc (INSP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inspire Medical data highlights cardiovascular outcomes with neuromod for sleep apnea - MassDevice
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study - marketscreener.com
Inspire sleep apnea implant linked to fewer heart, stroke events - Stock Titan
Discipline and Rules-Based Execution in INSP Response - Stock Traders Daily
Oppenheimer reiterates Perform on Inspire Medical stock amid challenges By Investing.com - Investing.com Canada
Inspire Medical Systems, Inc. (INSP): Growth Potential and Investor Outlook in the Healthcare Sector - DirectorsTalk Interviews
Inspire Medical Systems Inc (INSP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
INSP Technical Analysis & Stock Price Forecast - Intellectia AI
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight - The Manila Times
Inspire Medical to discuss sleep apnea tech at Wells Fargo MedTech event - Stock Titan
Alphatec vs. Inspire Medical Systems: Investment Profiles in Medical DevicesNews and Statistics - IndexBox
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Healthcare Sector with a 26.65% Potential Upside - DirectorsTalk Interviews
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff - Seeking Alpha
Behavioral Patterns of INSP and Institutional Flows - Stock Traders Daily
Inspire Medical Systems Hits 52-Week Low at $39.29 Amidst Major Decline - Markets Mojo
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report? - Yahoo Finance
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now - Yahoo Finance
1 Profitable Stock Worth Your Attention and 2 We Find Risky - Yahoo Finance
Inspire Medical Systems stock hits 52-week low at 39.51 USD - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at 39.51 USD By Investing.com - Investing.com South Africa
Inspire Medical Deadline Reminder - TMX Newsfile
Mairs & Power Small Cap Fund's Inspire Medical Systems Inc(INSP) Holding History - GuruFocus
Can Inspire Medical Systems (INSP) Convert Revenue Beats Into Sustainable Earnings Strength? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside - DirectorsTalk Interviews
Cash Machine Trading Cheap – Inspire Medical Systems Stock Set to Run? - Trefis
Inspire Medical Systems Stock: Strong Cash Flow Poised for a Re-Rating? - Trefis
Inspire Medical Systems Inc (INSP) Shares Fall 4.0% -- What GF S - GuruFocus
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? - Insider Monkey
Soleus files 1.47M-share stake in Inspire Medical Systems (INSP) - Stock Titan
Analyst warns Inspire Medical has a problem lasting into 2028 - thestreet.com
Inspire Medical Systems (INSP) Cuts 2026 Outlook Amid Medicare Uncertainty and Insider Sale – What’s Changed? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a Potential 18.99% Upside in the Healthcare Sector - DirectorsTalk Interviews
A Look At Inspire Medical Systems (INSP) Valuation As Analyst Caution Rises On Reimbursement Coding Risks - Sahm
(INSP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inspire Medical drops as BofA cuts to underperform on lack of coding clarity - MSN
Here's why you should add Inspire Medical stock to your portfolio now - MSN
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39 - Moomoo
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
Inspire Medical Systems, Inc. Common Stock (NY: INSP - The Chronicle-Journal
BofA analysts downgrade Inspire Medical on reimbursement coding concerns - MassDevice
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):